Forbedring i brofibrose viste sig hos 19/ 30 (63%) patienter uden YMDD- variant og hos 22/ 44 (50%) patienter med varianten.
Improvement in bridging fibrosis occurred in 19/ 30 (63%) patients without YMDD variant and 22/ 44 (50%) patients with the variant.